Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Condition(s):Multiple MyelomaLast Updated:November 28, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:November 28, 2023Terminated
Condition(s):MyelomaLast Updated:May 13, 2016Terminated
Condition(s):Multiple Myeloma; Patient ParticipationLast Updated:June 17, 2020Terminated
Condition(s):Multiple MyelomaLast Updated:May 3, 2011Withdrawn
Condition(s):RetinoblastomaLast Updated:May 15, 2023Active, not recruiting
Condition(s):Hepatocellular Carcinoma (HCC)Last Updated:December 18, 2017Withdrawn
Condition(s):Multiple MyelomaLast Updated:April 21, 2020Completed
Condition(s):Melanoma, OcularLast Updated:December 21, 2023Completed
Condition(s):Multiple MyelomaLast Updated:August 19, 2013Unknown status
Condition(s):Castrate Resistant Prostate CancerLast Updated:April 19, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.